Abstract
We report a case of phenytoin-associated Hodgkin's disease of lymphocyte predominance subtype, which developed after two years of phenytoin (Epanutin) treatment. Four other English cases of phenytoin-associated lmphoid malignancy are also reviewed.
Full text
PDF


Contributor Information
T. K. Daneshmend, University Department of Medicine
J. D. Davies, University Department of Pathology, Bristol Royal Infirmary, Bristol BS2 8HW

